Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was USD 0.07 million compared to USD 0.02 million a year ago. Net loss was USD 3.93 million compared to net income of USD 23.09 million a year ago. Basic loss per share from continuing operations was USD 4 compared to basic earnings per share from continuing operations of USD 99.8 a year ago. Diluted loss per share from continuing operations was USD 4 compared to diluted earnings per share from continuing operations of USD 97.7 a year ago.